Compare VECO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VECO | NEO |
|---|---|---|
| Founded | 1945 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 1996 | 2008 |
| Metric | VECO | NEO |
|---|---|---|
| Price | $53.03 | $17.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $61.33 | $19.72 |
| AVG Volume (30 Days) | 513.9K | ★ 1.6M |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $664,294,000.00 | N/A |
| Revenue This Year | $16.95 | $10.55 |
| Revenue Next Year | $31.92 | $10.07 |
| P/E Ratio | $289.44 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.00 | $7.07 |
| 52 Week High | $86.63 | $20.05 |
| Indicator | VECO | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 59.38 | 51.40 |
| Support Level | $50.39 | $18.27 |
| Resistance Level | $54.82 | $19.90 |
| Average True Range (ATR) | 1.99 | 0.82 |
| MACD | 1.23 | -0.17 |
| Stochastic Oscillator | 83.73 | 36.66 |
Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The maximum of the company's revenue is generated from sales to the Semiconductor Industry and within China.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.